Your browser doesn't support javascript.
loading
Indwelling central venous catheter infection with Chryseobacterium shandongense - successful eradication in a 5-year-old with cystic fibrosis.
Rowan, Anthony; Verbruggen, Tiarnan Fallon; O'Connell, Nuala H; Stapleton, Patrick J; Dunne, Colum P; Linnane, Barry; Butler, Daryl.
Afiliação
  • Rowan A; Department of Paediatrics, University Hospital Limerick, Dooradoyle, Limerick, Ireland.
  • Verbruggen TF; Department of Paediatrics, University Hospital Limerick, Dooradoyle, Limerick, Ireland.
  • O'Connell NH; Department of Microbiology, University Hospital Limerick, Dooradoyle, Limerick, Ireland.
  • Stapleton PJ; School of Medicine and Centre for Interventions in Infection, Inflammation and Immunity (4i), University of Limerick, Limerick, Ireland.
  • Dunne CP; Department of Microbiology, University Hospital Limerick, Dooradoyle, Limerick, Ireland.
  • Linnane B; School of Medicine and Centre for Interventions in Infection, Inflammation and Immunity (4i), University of Limerick, Limerick, Ireland.
  • Butler D; Department of Paediatrics, University Hospital Limerick, Dooradoyle, Limerick, Ireland.
Access Microbiol ; 5(12)2023.
Article em En | MEDLINE | ID: mdl-38188240
ABSTRACT

Introduction:

Chryseobacterium shandongense is a Gram-negative Flavobacterium bacillus with intrinsic multidrug-resistant properties. Case Presentation Herein, we present the first case report of human C. shandongense infection, relating to an implantable portal and catheter (port-a-cath) central line in a 5-year-old female with cystic fibrosis. The infection was identified using a Bruker MALDI-TOF Biotyper with BDAL (v12) of blood, which was cultured due to pyrexia and rigour following port-a-cath access. This report details the effective eradication of C. shandongense infection from the port-a-cath device using initial empirical gentamicin followed by targeted ciprofloxacin locks and systemic antibiotics.

Conclusion:

We demonstrated successful eradication of C. shandongense from a port-a-cath device, including the minimum inhibitory concentrations (MICs) required in this case. The result was eradication of central access infection, preventing progression to bacteraemia/septicaemia and preserving central access in a child with cystic fibrosis and established respiratory disease.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article